Home > Healthcare > Medical Devices > Diagnostic Devices > Esoteric Testing Market

Esoteric Testing Market Trends

Report ID: GMI1922
Published Date: Mar 2022
Report Format: PDF

Download Free Sample

Esoteric Testing Market Trends

Increasing demand for genomics and proteomics coupled with growing investment for development of novel solutions to detect rare molecules in the body will impel overall industry growth. The large-scale testing of proteomics is the lifeblood of clinical translation and biological research. The novel improvements in mass-spectrometry-based proteomics and stronger co-operation between researchers and clinicians aid in understanding and detecting complex disease phenotypes.

Thus, the escalating demand for technologically progressive tests has brought significant investment in R&D that will strengthen the market growth potential in future. Design and development of novel test methods with numerous advantages for range of rare diseases will propel the global market demand.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global esoteric testing industry size had crossed USD 26 billion in 2021 and is pegged to record a 6.9% CAGR between 2022 and 2028 on account of the rising threat of complex and rare medical disorders worldwide.

The infectious disease and immunology test type segment held over 30% of the esoteric testing market share in 2021 owing to the higher burden of the diseases.

The esoteric testing market share from the chemiluminescence technology segment crossed USD 6.6 billion in 2021 and will grow with the rapidly rising usage for detecting the analyte in low volume test samples.

The esoteric testing in North America is poised to observe a 6.1% CAGR through 2028 due to the surging awareness of the benefits of early disease detection and the rising adoption of esoteric diagnostic techniques in the region.